(Q69734281)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

title

Immunoscintigraphy using CA 125 antibodies in the management of ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

1 reference

Mucin 16, cell surface associated

1 reference

J Brökelmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

A Bockisch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

J Vogel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

J Reinsberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

P Oehr

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

H J Biersack

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

D Krebs

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

Archives of Gynecology and Obstetrics

5 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

volume

244

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

5 October 2019

page(s)

193-206

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2782949%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01560083

5 October 2019

exact match

0 references

cites work

Evaluation of serum CA 125 levels in the monitoring of ovarian cancer

1 reference

12 December 2020

Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndrome

1 reference

12 December 2020

Predictive value of serial CA 125 antigen levels in ovarian cancer evaluated by second-look laparotomy

1 reference

12 December 2020

CA-125. Use as a tumor marker with mixed mesodermal tumors of the female genital tract

1 reference

12 December 2020

Serum CA-125 in the evaluation of benign adnexal cysts

1 reference

12 December 2020

Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy

1 reference

12 December 2020

Initial assessment of tumor-associated antigen CA-125 in patients with ovarian, cervical, and testicular tumors

1 reference

12 December 2020

Pronounced increases in the concentration of an ovarian tumor marker, CA-125, in serum of a healthy subject during menstruation

1 reference

12 December 2020

Peritoneal tuberculosis with elevated serum CA 125 levels: a case report

1 reference

12 December 2020

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

1 reference

12 December 2020

Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma

1 reference

12 December 2020

Increased serum CA 125 levels during the first trimester of pregnancy

1 reference

12 December 2020

Chemotherapy of dysgerminoma

1 reference

12 December 2020

CA-125 in gynecological malignancies

1 reference

12 December 2020

Serum CA 125 in epithelial ovarian cancer. A longitudinal study

1 reference

12 December 2020

CA 125 in the serum and tissue of patients with gynecological disease

1 reference

12 December 2020

Cell heterogeneity in human ovarian carcinoma.

1 reference

12 December 2020

The clinical significance of pre-operative serum CA 125 in ovarian cancer

1 reference

12 December 2020

Immunoradiometric assay of CA 125 in effusions. Comparison with carcinoembryonic antigen

1 reference

12 December 2020

Role of Ca 125 as tumor marker in ovarian carcinoma

1 reference

12 December 2020

[Radioimmunoscintigraphy in ovarian cancer: theoretical principles and clinical experiences]

1 reference

12 December 2020

CA 125 surveillance and second-look laparotomy in ovarian carcinoma

1 reference

12 December 2020

Radiolabeled monoclonal anti-tumor antibodies in diagnosis and therapy

1 reference

12 December 2020

Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer

1 reference

12 December 2020

[High Ca 125 serum level in benign ascites or pleural effusion]

1 reference

12 December 2020

Explanation of the limited correlation between tumor CA 125 content and serum CA 125 antigen levels in patients with ovarian tumors

1 reference

12 December 2020